2nd Exam Flashcards
Medications that are used to treat benign prostatic hyperplasia (BPH)
5-alpha
reductase inhibitors and alpha1-adrenergic antagonists.
Medications used to treat
erectile dysfunction
phosphodiesterase type 5 (PDE5) inhibitors
needed for growth and maturation of the female reproductive
tract and secondary sex characteristics.
Estrogens
block bone resorption and reduce
low-density lipoprotein (LDL) levels.
Estrogens
suppress the release of a
follicle-stimulating hormone (FSH) needed for conception.
estrogens
a hormone secreted by the corpus luteum and adrenal glands. It is responsible for changes in uterine endometrium in the second half of the menstrual
cycle in preparation for implantation of the fertilized ovum, development of maternal
placenta after implantation, and development of mammary glands.
Progesterone
Synthetic drug that exert progesterone like activity are called
progestins.
Use to treat symptoms of menopause, prevent long-term consequences of
estrogen loss, and in some cases, to treat prostate and breast cancer
HORMONE REPLACEMENT THERAPY
stimulate uterine contractions. Use to induce labor.
Oxytocics
Oxytocics interact with several drugs including vasoconstrictors which may lead to
hypertension.
inhibit uterine contractions.
Uses to prevent preterm labor.
Tocolytics - Terbutaline (beta -2-adrenergic agonist)
Adverse effects of tocolytics
tachycardia in mother and fetus.
Nursing Considerations for Tocolytics
monitor heart rate of mother and fetus
Treatment for Male Hypogonadism
testosterone or other androgens
Use to restore normal gonadal development and secondary male sex
characteristics.
testosterone
Adverse effects of testosterone
water retention, edema, potential for liver damage,
acne, skin irritation.
provide education to client, monitor client’s
condition, monitor liver enzymes, physical assessment for signs of increased or
decreased sex hormone production
Nursing consideration for testosterone
Treatment for Erectile dysfunction
sildenafil (Viagra)
Use to treatment of erectile dysfunction. acts by relaxing smooth muscle in the corpus cavernosum,
allowing increased blood flow into the penis, resulting in a firmer and longer-lasting
erection.
sildenafil (Viagra)
Severe chest pain that is usually short (lasts 5-10mins)
- Brought on by exertion or emotional excitement
Angina Pectoris
- Spasms of the coronary artery leads to decreased myocardial blood flow
- Not specifically related to plaque build up
- Pain related to vasoconstriction of artery
- Generally, occurs in periods of rest
Vasospastic (Prinzmetal’s) Angina
- Episodes occur suddenly, increasing intensity, and occur during periods
of rest - Plaque within coronary artery ruptures
- Medical emergency
- Does not go away and leads to an M
Unstable Angina (most severe form of angina)
Antianginal Drugs
❖ Calcium Channel Blocker
❖ Nitrates (Nitroglycerin)
❖ Beta-Adrenergic Blockers (Cardioprotective - reduces the incidence of MI)
relax coronary artery spasm, causes negative inotropic effects,
and reduces cardiac workload and oxygen demands
Calcium Channel Blocker
what are the side effects of Calcium Channel Blocker
dizziness, flushing, headache, hypotension, reflex
tachycardia, peripheral edema, fatigue
forms nitric oxide in vascular smooth muscle, causes
vasodilation
Nitrates (Nitroglycerin)
Reduces the amount of blood returning to the heart (preload),
Reduced cardiac output, Reduced workload, Reduced
oxygen demands
vasodilation
Nitrates (Nitroglycerin) is given in what medicine route?
sublingually
decreases the cardiac workload by lowering blood pressure,
slowing heart rate and reducing contractility Also effective for HTN
Beta-Adrenergic Blockers (Cardioprotective - reduces the incidence of MI)
Preferred selective beta blockers because non-selective can
affect
bronchodilation
Occur in all age groups, in healthy and unhealthy people too, Associated conditions/diseases: HTN, cardiac valve disease, CAD, hyper/hypokalemia, MI, stroke, DM, HF
Dysrhythmias
Signs and Symptoms of Dysrhythmias
Dizziness, weakness, fatigue, decreased exercise tolerance,
palpitations, dyspnea, syncope (temp. Loss of consciousness due to decrease in BP)
- Action potential begins when threshold potential is reached.
- Sodium rushes in, producing rapid depolarization
- Calcium enters at a slower rate
Phase 0
- Brief transient phase
- Inside of plasma membrane reverses charge, becomes positive
Phase 1
- Plateau reached in which depolarization is maintained
- Contraction of cardiac muscle
- Efflux of potassium from cells
Phase 2
- Calcium channels close
- Additional potassium channels open
- Repolarization returns negative resting membrane potential
Phase 3
- Refractory Period
- Brief period where depolarization cannot occur
- Ensures myocardial cell finishes contracting before another
action potential begins
Phase 4
- HR <60 bpm
- Common among older adults
- Major indication for pacemakers
Bradydysrhythmias
Common bradydysrhythmias
Sinus bradycardia -life sustainable
Sinoatrial node dysfunction (HR in the 30s)
Atrioventricular (AV) conduction block
Arrhythmia - no rhythm (DEAD)
- HR >100 bpm
- Incidence increases in older adults and those with preexisting cardiac disease
Tachydysrhythmias
Common tachydysrhythmias:
Atrial tachycardia
Atrial flutter
Atrial fibrillation
Ventricular tachycardia
Ventricular fibrillation
Paroxysmal supraventricular tachycardia (PSVT) >200 bpm
Atrial tachycardia
- No treatment
- Little or no benefit to treatment with medications
Asymptomatic dysrhythmias
- Initiated for high-risk patients
- Avoid drug combinations that increase QT interval
Prophylaxis of dysrhythmias
- Cardioversion or defibrillation
- Electrical stimulation of the heart for serious dysrhythmias
- Pacemakers
- ICDs (implantable cardioverter defibrillators)
Nonpharmacologic treatment of dysrhythmias
- Uses: Ventricular tachycardia during CPR, Refractory ventricular
fibrillation during CPR, Pulseless ventricular tachycardia during CPR,
Premature atrial tachycardia, Atrial flutter, Atrial fibrillation - Action:
- Blocks sodium ion channels in myocardial cells
- Reduces automaticity and slows velocity of action potential
- Adverse Effects:
- Nausea and vomiting, headache, fever, anorexia, weakness,
confusion, psychosis at high doses
Class 1A: procainamide
Pharmacologic management of dysrhythmias
Sodium Channel Blockers (works in phase 0 of action potential)
Class 1A: procainamide
Class 1B:
Class 1C: Antiarrhythmics
Beta Adrenergic Antagonist: Class II
Potassium Channel Blockers: Class III
Calcium Channel Blockers: Class IV
Other Management of Dysrhythmias:
Adenosine (transient heart block)
Digoxin
- Check apical and radial pulses before dose
- Continuous ECG and BP monitoring during IV administration
- Monitor therapeutic blood levels
Nursing Responsibilities for Class 1A
- Shorten repolarization
- Primary indications are ventricular dysrhythmias
Class 1B
Drugs included in Class 1B
- Lidocaine (Xylocaine)
- Mexiletine (Mexitil)
- Phenytoin (Dilantin)
- Decrease conduction velocity
- PR, QRS, and QT intervals are often prolonged
- Life-threatening atrial dysrhythmias
Class 1C: Antiarrhythmics
- Reduce automaticity as well as slow conduction velocity in the heart
- Action: block calcium channels in SA and AV nodes
- Slows HR
Beta Adrenergic Antagonist: Class II
Drugs included in Beta Adrenergic Antagonist: Class II
- Acebutolol (Sectral)
- Esmolol (Brevibloc)
- Propranolol (Inderal)
- Block potassium ion channels in myocardial cells
- Limited use due to serious AE such as:
- N/V, anorexia, fatigue, dizziness, hypotension, visual
disturbances, rashes, photosensitivity
Potassium Channel Blockers: Class II
- Exact mechanism unknown
- Block potassium channels but also blocks sodium ion channels
and inhibits sympathetic activity
Potassium Channel Blockers: Class III
severe bradycardia, cardiogenic shock,
sick sinus syndrome, severe sinus node dysfunction, third-degree AV
block, hypersensitivity to iodine, lactation, COPD, electrolyte imbalances
Contraindications/precautions of Potassium Channel Blockers: Class III
- Monitor BP during IV infusion
- Assess for adverse effects
- Baseline lab tests
- Assess respiratory status
- Supervise ambulation (could have hypotension)
- Baseline ophthalmic exam
Nursing Responsibilities for Class III
- Effects similar to those of beta - adrenergic antagonists
- Monitor for bradycardia and hypotension
Calcium Channel Blockers: Class IV
- Naturally occurring nucleoside
- Activates potassium channels in SA and AV nodes
- Terminates tachycardia
- Primary indication is PSVT (very common)
- 10-second half-life, so adverse effects are self-limiting
Adenosine (transient heart block)
- Primarily for HF
- Not effective against ventricular dysrhythmias
- Patients must be carefully monitored for toxicity, drug interactions, and
adverse effects - Loading dose neede
Digoxin
Prevent the formation of clots, but do not take care of current clots
- Use: venous and arterial disorders at high risk for clot formation of DVT, PE, MI, artificial heart valves, strokes
Anticoagulants
binds with antithrombin iii, inhibits the action of thrombin,
inhibits the conversion of fibrinogen to fibrin, therefore inhibiting clot
formation
- Use: prevent venous thrombosis
- Issues: Must be given IV or SC (Not PO because of first pass), monitor
laboratory (PT/INR, aPTT), side effects of bleeding and bruising
HEPARIN
Antidote of Heparin
Protamine sulfate
inactivates Xa factor
Use: prevent DVT, PE (high risk from abdominal and orthopedic
surgeries)
- Issues: ASA (aspirin), bleeding
Low Molecular weight heparin
directly inhibits thrombin, preventing fibrinogen from converting to
fibrin
- Use: treatment and prevention of DVT/PE, and thrombus prophylaxis for
unstable angina, a-fib, and stroke
- Issues: IV, SC
Direct Thrombin Inhibitors
: inhibits synthesis of vitamin K, clotting factors II, VII, IX, and X
are affected
- Use: prevents thromboembolic conditions (thrombophlebitis, PE, DVT)
- Issues: monitor labs (PT/INR)
WARFARIN
Antidote of WARFARIN
Vitamin K, takes 24-48 hours to be effective and may need
to give frozen plasma or platelets in the meantime
Prevent platelet aggregation, interrupts the cascade (the enzyme that
helps them aggregate is no longer available)
Antiplatelets
Inhibits cyclooxygenase (needed for platelet aggregation)
- Use: prevent MI and TE, prevent and treat a stroke
- Issues: bleeding and GI upset
ASPIRIN
ind to fibrin promoting conversion of plasminogen to plasmin
- Uses: DVT, PE, MI (clots)
- Issues: anaphylaxis, reperfusion dysrhythmias, hemorrhage
- Only used for treatment and not prevention
- 3-4 hours after the event occurs can you give this med
Thrombolytics
- Used for hypertension, heart failure, renal failure, liver failure, and pulmonary edema
- Common adverse effects: dehydration, hypotension, electrolyte imbalance
Diuretics
5 types of Diuretics
Thiazide and Thiazide-Like Diuretics
Loop Diuretics (Lasix)
Osmotic Diuretics
Carbonic Anhydrase Inhibitors
Potassium Sparing Diuretics
act on the distal convoluted renal tubule; promotes
sodium, chloride, and water excretion (may also lose K and Mg)
Thiazide and Thiazide-Like Diuretics
Use of Thiazide and Thiazide-Like Diuretics
HTN and peripheral edema
dizziness, headache, weakness, hypotension, GI
distress, constipation, hyperglycemia, electrolyte imbalance,
urticarial, hyperuricemia, blood dyscrasias, renal failure
Side effects of Thiazide and Thiazide-Like Diuretics
Contradictions of Thiazide and Thiazide-Like Diuretics
renal failure
act on the ascending loop of Henle; secretes Na, water, K, Ca, Mg
Loop Diuretics (Lasix)